WellDoc racks up $29.5 mln Series B as J&J joins round
Johnson & Johnson Innovation – JJDC Inc joined WellDoc's Series B financing round, bringing the round's total to $29.5 million. As announced in December, Samsung Ventures led WellDoc's initial Series B raise with existing investor Merck Global Health Innovation Fund serving as co-lead. WellDoc also announced a partnership with LifeScan Inc, a blood glucose monitoring business within the Johnson & Johnson Diabetes Care Companies. Baltimore-based WellDoc develops mobile solutions to drive behavioral and clinical change in chronic disease.
1 March 2016•3 mins read
